Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
- DOI
- 10.1093/jnci/djag063
- Published
- 2026 Jul 1
- Container
- Journal of the National Cancer Institute
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/jnci/djag063,
title = {Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.},
author = {Sampathkumar Y and Zakaria Z and O'Connell K and Bhimani J and Blinder VS and Burganowski R and Ergas IJ and Gallagher GB and Griggs JJ and Heon N and Kolevska T and Kotsurovskyy Y and Kroenke CH and Laurent CA and Liu R and Monroy-Iglesias MJ and Nakata KG and Persaud S and Roh JM and Tabatabai S and Valice E and Wang P and Bandera EV and Aiello Bowles EJ and Kushi LH and Kantor ED},
year = {2026},
journal = {Journal of the National Cancer Institute},
doi = {10.1093/jnci/djag063},
url = {https://doi.org/10.1093/jnci/djag063}
}RIS
TY - JOUR TI - Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer. AU - Sampathkumar Y AU - Zakaria Z AU - O'Connell K AU - Bhimani J AU - Blinder VS AU - Burganowski R AU - Ergas IJ AU - Gallagher GB AU - Griggs JJ AU - Heon N AU - Kolevska T AU - Kotsurovskyy Y AU - Kroenke CH AU - Laurent CA AU - Liu R AU - Monroy-Iglesias MJ AU - Nakata KG AU - Persaud S AU - Roh JM AU - Tabatabai S AU - Valice E AU - Wang P AU - Bandera EV AU - Aiello Bowles EJ AU - Kushi LH AU - Kantor ED PY - 2026 JO - Journal of the National Cancer Institute DO - 10.1093/jnci/djag063 UR - https://doi.org/10.1093/jnci/djag063 ER -
APA
Y, S., Z, Z., K, O., J, B., VS, B., R, B., IJ, E., GB, G., JJ, G., N, H., T, K., Y, K., CH, K., CA, L., R, L., MJ, M., KG, N., S, P., JM, R., S, T., E, V., P, W., EV, B., EJ, A. B., LH, K., & ED, K. (2026). Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag063
Source records
- pubmed · retrieved 2026-09-26T21:47:28.290Z